An epidemiological study to evaluate the use of vitamin K antagonists and new oral anticoagulants among non-valvular atrial fibrillation patients in Turkey- AFTER-2 study design
Tarih
2015Yazar
Kobat, Mehmet Ali
Zengin, Halit
Gunduz, Mahmut
TUNÇEZ, ABDULLAH
KARAVELİOĞLU, YUSUF
Gokdeniz, Tayyar
KOZA, Yavuzer
Aktop, Ziyaeddin
Katlandur, Huseyin
KARACA ÖZER, Pelin
YÜKSEL, MURAT
ACET, HALİT
ÇİL, HABİB
Alan, Sait
Ertas, Faruk
KAYA, HASAN
YILDIZ, ABDULKADİR
Davutoglu, Vedat
Kiris, Abdulkadir
Dinc, Lale
Kafes, Habibe
Avci, Anil
ÇALAPKORUR, Bekir
Ertas, Gokhan
Gul, Mehmet
KAHRAMAN AY, NURAY
Bulur, Serkan
Durukan, Mine
Eren, Murat
Ilhan, Ibrahim
TOPRAK, NİZAMETTİN
KÜÇÜK, MURATHAN
ÖZPELİT, EBRU
Şimşek, Hakkı
Ucar, F. Mehmet
Yildiz, Ahmet
Sahin, D. Yildiray
Ayhan, Erkan
Caglayan, C. Emre
GÜNGÖR, HASAN
Ozyurtlu, Ferhat
Sen, Nihat
Vatan, Bulent
Vatansever, Fahriye
Temiz, Ahmet
TAYLAN, GÖKAY
Donmez, Ibrahim
Erkus, M. Emre
Soylemez, Selami
Üst veri
Tüm öğe kaydını gösterÖzet
Objectives: Atrial fibrillation (AF) is one of the most common causes of preventable ischemic stroke and is related to increased cardiovascular morbidity and mortality. There is a lack of data in Turkey on the use of new oral anticoagulants (NOACs), and time in therapeutic INR range (TTR) in vitamin K antagonist users and AF management modality. In this multi-center trial, we aimed to analyze, follow and evaluate the epidemiological data in non-valvular AF patients.
Koleksiyonlar
- Makale [92796]